ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 734187 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 734187; 2) Community: the network communities that were significantly associated with the response to NSC 734187; 3) Molecule: the relationships between components within communities and NSC 734187; 4) MDR: the compounds that were significantly associated with the NSC 734187.

NSC Compound Enrichment Correlation
NSC 706995 Entinostat 0.0454469012959173 -0.01640814
NSC 714380 Null 0.0454469012959173 0.035368174
NSC 721075 Claritin 0.0454469012959173 0.0069302078
NSC 722877 Null 0.0454469012959173 0.13033268
NSC 727987 NSC 708783 incorporated in micelles, 0.20% (w/w) of drug 0.0454469012959173 0.15937591
NSC 732800 methyl 4-[3-chloro-4-(3-chloro-2-methylanilino)-2,5-dioxo-2,5-dihyd ro-1H-1-pyrrolylmethyl]benzoate 0.0454469012959173 0.16676236
NSC 100071 component of Halotex 0.0459335986102865 0.11487009
NSC 12097 Resorufine 0.0459335986102865 0.34847783
NSC 123461 Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) 0.0459335986102865 0.36454844
NSC 123463 Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) (8CI) 0.0459335986102865 0.44905282
Total:152  Current:137    [First] [Prev] [Next] [Last]